LKFT34:BVMF
Lakefront Biotherapeutics Nv Bdr
R$7.45
arrow_downward
-0.40%(-0.030) 1D
Oct 13, 10:11:23 AM GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LKFT34...
Open
R$7.45
High
R$7.45
Low
R$7.45
Mkt. cap
1.73B
Avg. vol.
141.00
Volume
1.00
52-wk high
R$8.08
52-wk low
R$5.97
Shares outstanding
65.90M
No. of employees
196
Open
R$7.45
High
R$7.45
Low
R$7.45
Mkt. cap
1.73B
Avg. vol.
141.00
Volume
1.00
52-wk high
R$8.08
52-wk low
R$5.97
Shares outstanding
65.90M
No. of employees
196
News stories
From web sources and news partners
MarketBeat
·
3 minutes ago
EverQuote, Inc. (NASDAQ:EVER) Stock Now Rated "Moderate Buy" by Sell-Side Analysts
TradingView
·
1 hour ago
NYSE Touches Down at TechCrunch Disrupt: NYSE Content Update
Moomoo
·
19 minutes ago
[U.S. Equities] Dow Inc and Nasdaq trade in narrow range (morning of the 13th)
CNBC
·
46 minutes ago
Opening Bell: October 13 2026
Profile
Lakefront Biotherapeutics is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb.
The company develops drugs against rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, systemic lupus erythematosus and cystic fibrosis. Wikipedia
About Lakefront Biotherapeutics Nv Bdr
CEOPaul Stoffels | Paul Stoffels
Employees196
Founded1999
Headquarters-
SectorBiotechnology
Websitelakefrontbio.com